Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00235495 · ClinicalTrials.gov registry record · Phase 3
Albumin in Acute Ischemic Stroke Trial
A Phase 3 study, sponsored by University of Miami.
- Terminated
- Registry status
- Phase 3
- Development phase
- 841
- Enrollment target
NCT00235495 is a Phase 3 study that was terminated before completion, run by University of Miami. The registered enrollment target is 841 participants.
The verdict
NCT00235495, a Phase 3 study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 841 participants
- Enrollment target
Study Summary
The goal of the trial is to determine whether human albumin, administered within 5 hours of symptom onset, improves the 3-month outcome of subjects with acute ischemic stroke.
Interventions
- DRUG Saline
- BIOLOGICAL Albumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 841 participants |
| Start Date | 2006-06 |
| Est. Completion | 2013-02 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00235495
The ClinicalTrials.gov registry entry for NCT00235495 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 841 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline is the first listed.
NCT00235495 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00235495 about?
NCT00235495 is a clinical study titled "Albumin in Acute Ischemic Stroke Trial". The goal of the trial is to determine whether human albumin, administered within 5 hours of symptom onset, improves the 3-month outcome of subjects with acute ischemic stroke.
What is the current status of trial NCT00235495?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 841 participants. The study started on 2006-06. Estimated completion is 2013-02.
What interventions are being tested in trial NCT00235495?
The interventions under investigation include: Saline (DRUG), Albumin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00235495?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.